BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1567-1578

  Gupta, Vivek ^a   You, Yuyi ^a   Li, Jonathan ^a   Gupta, Veer ^b   Golzan, Mojtaba ^a   Klistorner, Alexander ^a,f   van den Buuse, Maarten ^c,d,e   Graham, Stuart ^a,f  

^a MACQUARIE UNIVERSITY   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amyloid beta; Brain derived neurotrophic factor; Ganglion cell layer; Glaucoma; Signal transduction; TrkB receptor

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL GLAUCOMA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OPTIC NERVE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; AGE; ANIMAL MODEL; GLAUCOMA; INNER RETINA; INTRAOCULAR PRESSURE; RETINA GANGLION CELL;

AMYLOID BETA; BRAIN-DERIVED NEUROTROPHIC FACTOR; GANGLION CELL LAYER; GLAUCOMA; SIGNAL TRANSDUCTION; TRKB RECEPTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANIMALS; AUTOPSY; AXONAL TRANSPORT; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLAUCOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, KNOCKOUT; OPTIC NERVE; PEPTIDE FRAGMENTS; RECEPTOR, TRKB; RETINA; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84903750561     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.026     Document Type: Article

References (58)

1. Ramdas W.D., van Koolwijk L.M., Lemij H.G., Pasutto F., Cree A.J., Thorleifsson G., Janssen S.F., Jacoline T.B., Amin N., Rivadeneira F., Wolfs R.C., Walters G.B., Jonasson F., Weisschuh N., Mardin C.Y., Gibson J., Zegers R.H., Hofman A., de Jong P.T., Uitterlinden A.G., Oostra B.A., Thorsteinsdottir U., Gramer E., Welgen-Lussen U.C., Kirwan J.F., Bergen A.A., Reis A., Stefansson K., Lotery A.J., Vingerling J.R., Jansonius N.M., Klaver C.C., van Duijn C.M. Common genetic variants associated with open-angle glaucoma. Hum. Mol. Genet. 2011, 20:2464-2471.
2. Ramdas W.D., van Koolwijk L.M., Cree A.J., Janssens A.C., Amin N., de Jong P.T., Wolfs R.C., Gibson J., Kirwan J.F., Hofman A., Rivadeneira F., Oostra B.A., Uitterlinden A.G., Ennis S., Lotery A.J., Lemij H.G., Klaver C.C., Vingerling J.R., Jansonius N.M., van Duijn C.M. Clinical implications of old and new genes for open-angle glaucoma. Ophthalmology 2011, 118:2389-2397.
3. Stone E.M., Fingert J.H., Alward W.L., Nguyen T.D., Polansky J.R., Sunden S.L., Nishimura D., Clark A.F., Nystuen A., Nichols B.E., Mackey D.A., Ritch R., Kalenak J.W., Craven E.R., Sheffield V.C. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
4. McKinnon S.J. Glaucoma: ocular Alzheimer's disease?. Front. Biosci. 2003, 8:s1140-s1156.
5. Lambert W.S., Clark A.F., Wordinger R.J. Neurotrophin and Trk expression by cells of the human lamina cribrosa following oxygen-glucose deprivation. BMC Neurosci. 2004, 5:51.
6. Peinado-Ramon P., Salvador M., Villegas-Perez M.P., Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 1996, 37:489-500.
7. Unoki K., LaVail M.M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest. Ophthalmol. Vis. Sci. 1994, 35:907-915.
8. Ma Y.T., Hsieh T., Forbes M.E., Johnson J.E., Frost D.O. BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death. J. Neurosci. 1998, 18:2097-2107.
9. Weibel D., Kreutzberg G.W., Schwab M.E. Brain-derived neurotrophic factor (BDNF) prevents lesion-induced axonal die-back in young rat optic nerve. Brain Res. 1995, 679:249-254.
10. Mansour-Robaey S., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1632-1636.
11. Cohen-Cory S., Fraser S.E. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 1995, 378:192-196.
12. Carmignoto G., Maffei L., Candeo P., Canella R., Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J. Neurosci. 1989, 9:1263-1272.
13. Mey J., Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993, 602:304-317.
14. Chen H., Weber A.J. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest. Ophthalmol. Vis. Sci. 2001, 42:966-974.
15. Jelsma T.N., Friedman H.H., Berkelaar M., Bray G.M., Aguayo A.J. Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve. J. Neurobiol. 1993, 24:1207-1214.
16. Gupta V.K., You Y., Li J.C., Klistorner A., Graham S.L. Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J. Mol. Neurosci. 2013, 49:96-104.
17. Iwabe S., Moreno-Mendoza N.A., Trigo-Tavera F., Crowder C., Garcia-Sanchez G.A. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma. Vet. Ophthalmol. 2007, 10(Suppl. 1):12-19.
18. Klocker N., Kermer P., Weishaupt J.H., Labes M., Ankerhold R., Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase B signaling. J. Neurosci. 2000, 20:6962-6967.
19. Cheng L., Sapieha P., Kittlerova P., Hauswirth W.W., Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 2002, 22:3977-3986.
20. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001, 11:272-280.
21. Bartkowska K., Turlejski K., Djavadian R.L. Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol. Exp. 2010, 70:454-467.
22. Herzog K.H., von Bartheld C.S. Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J. Neurosci. 1998, 18:2891-2906.
23. Moretto G., Xu R.Y., Walker D.G., Kim S.U. Co-expression of mRNA for neurotrophic factors in human neurons and glial cells in culture. J. Neuropathol. Exp. Neurol. 1994, 53:78-85.
24. DiStefano P.S., Friedman B., Radziejewski C., Alexander C., Boland P., Schick C.M., Lindsay R.M., Wiegand S.J. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992, 8:983-993.
25. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000, 41:3460-3466.
26. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2000, 41:764-774.
27. Ko M.L., Hu D.N., Ritch R., Sharma S.C., Chen C.F. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci. Lett. 2001, 305:139-142.
28. Hu Y., Cho S., Goldberg J.L. Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:1747-1754.
29. Qian M.D., Zhang J., Tan X.Y., Wood A., Gill D., Cho S. Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. J. Neurosci. 2006, 26:9394-9403.
30. Ghaffariyeh A., Honarpisheh N., Heidari M.H., Puyan S., Abasov F. Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma. Optom. Vis. Sci. 2011, 88:80-85.
31. Yoneda S., Hara H., Hirata A., Fukushima M., Inomata Y., Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn. J. Ophthalmol. 2005, 49:106-108.
32. Suh Y.H., Checler F. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 2002, 54:469-525.
33. De Strooper B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 2010, 90:465-494.
34. Poon W.W., Blurton-Jones M., Tu C.H., Feinberg L.M., Chabrier M.A., Harris J.W., Jeon N.L., Cotman C.W. beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol. Aging 2011, 32:821-833.
35. Devi L., Ohno M. Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One 2010, 5:e12974.
36. Kimura R., Devi L., Ohno M. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J. Neurochem. 2010, 113:248-261.
37. Chen H., Wei X., Cho K.S., Chen G., Sappington R., Calkins D.J., Chen D.F. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest. Ophthalmol. Vis. Sci. 2011, 52:36-44.
38. Gupta V.K., You Y., Klistorner A., Graham S.L. Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress. Biochim. Biophys. Acta 2012, 1822:1643-1649.
39. Richards A., Emondi A.A., Rohrer B. Long-term ERG analysis in the partially light-damaged mouse retina reveals regressive and compensatory changes. Vis. Neurosci. 2006, 23:91-97.
40. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., Ransom N.L., Tahzib N.G., Reitsamer H.A., Levkovitch-Verbin H., Quigley H.A., Zack D.J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest. Ophthalmol. Vis. Sci. 2002, 43:1077-1087.
41. Matrone C., Ciotti M.T., Mercanti D., Marolda R., Calissano P. NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13139-13144.
42. Cellerino A., Carroll P., Thoenen H., Barde Y.A. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol. Cell. Neurosci. 1997, 9:397-408.
43. Dutescu R.M., Li Q.X., Crowston J., Masters C.L., Baird P.N., Culvenor J.G. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1213-1221.
44. Ito Y., Shimazawa M., Tsuruma K., Mayama C., Ishii K., Onoe H., Aihara M., Araie M., Hara H. Induction of amyloid-beta(1-42) in the retina and optic nerve head of chronic ocular hypertensive monkeys. Mol. Vis. 2012, 18:2647-2657.
45. Walsh D.T., Montero R.M., Bresciani L.G., Jen A.Y., Leclercq P.D., Saunders D., AN E.L.-A., Gbadamoshi L., Gentleman S.M., Jen L.S. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol. Dis. 2002, 10:20-27.
46. Arancibia S., Silhol M., Mouliere F., Meffre J., Hollinger I., Maurice T., Tapia-Arancibia L. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 2008, 31:316-326.
47. Devi L., Ohno M. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 2012, 37:434-444.
48. Fukumoto N., Fujii T., Combarros O., Kamboh M.I., Tsai S.J., Matsushita S., Nacmias B., Comings D.E., Arboleda H., Ingelsson M., Hyman B.T., Akatsu H., Grupe A., Nishimura A.L., Zatz M., Mattila K.M., Rinne J., Goto Y., Asada T., Nakamura S., Kunugi H. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:235-242.
49. Olin D., MacMurray J., Comings D.E. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci. Lett. 2005, 381:275-278.
50. Ning A., Cui J., To E., Ashe K.H., Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest. Ophthalmol. Vis. Sci. 2008, 49:5136-5143.
51. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., Moss S.E., Fitzke F.W., Cordeiro M.F. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13444-13449.
52. Goldblum D., Kipfer-Kauer A., Sarra G.M., Wolf S., Frueh B.E. Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest. Ophthalmol. Vis. Sci. 2007, 48:5085-5090.
53. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 2008, 59:201-220.
54. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 1997, 49:71-81.
55. Rantamaki T., Kemppainen S., Autio H., Staven S., Koivisto H., Kojima M., Antila H., Miettinen P.O., Karkkainen E., Karpova N., Vesa L., Lindemann L., Hoener M.C., Tanila H., Castren E. The impact of BDNF gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease. PLoS One 2013, 8:e68722.
56. Massa S.M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J.N., Nehama D., Rajadas J., Longo F.M. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J. Clin. Invest. 2010, 120:1774-1785.
57. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 2004, 29:95-102.
58. Ortega F., Perez-Sen R., Morente V., Delicado E.G., Miras-Portugal M.T. P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons. Cell. Mol. Life Sci. 2010, 67:1723-1733.